Clinical and histopathological aspects of Kaposi's sarcoma in Africa: relationship with HIV serology. 1988

J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
Centre National Hospitalier et Universitaire, Bangui (République Centrafricaine).

From 1983 to 1987, 45 Kaposi's sarcomas (KS) were diagnosed at the University Hospital in Bangui; 37 cases were easily classified as either endemic or AIDS-related KS on clinical grounds and HIV serology. Moreover, probably due to the stage at which patients consulted and lesions were sampled, noticeable histopathological differences were observed between the two clinical presentations. But for 8/45 which we classified as "borderline KS", strong discrepancies occurred between clinical aspects, patient evolution, HIV serology and histopathology. In two cases, HIV-positive patients had typical endemic non-evolutive KS and have survived 15 and 36 months.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002488 Central African Republic A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui. Ubangi-Shari
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
July 1990, Clinical and experimental dermatology,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
January 1965, Annales des Societes belges de medecine tropicale, de parasitologie, et de mycologie,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
January 1991, Medecine tropicale : revue du Corps de sante colonial,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
February 1985, Lancet (London, England),
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
January 1991, Cancer surveys,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
January 1978, Vestnik dermatologii i venerologii,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
October 1992, Current opinion in oncology,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
October 1989, Minerva stomatologica,
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
December 1996, Lancet (London, England),
J L Lesbordes, and P M Martin, and P Ravisse, and M C Georges-Courbot, and A J Georges
January 1991, Cancer surveys,
Copied contents to your clipboard!